For both GBM and glioma, CXCL12 functions under hypoxic conditions in the CSC niche through an autocrine positive feedback loop that promotes cell survival, tumor progression, and cell proliferation, which can be inhibited by blocking CXCR4 [144,145]. The gene discussed is CXCR4; the disease is central nervous system cancer.